<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30112841</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>25</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2045-7634</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>7</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer medicine</Title>                <ISOAbbreviation>Cancer Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis.</ArticleTitle>            <Pagination>                <MedlinePgn>4801-4813</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.1572</ELocationID>            <Abstract>                <AbstractText>Cardiovascular disease has been identified as one of the late complications of cancer therapy. The purpose of this study was to quantify the long-term risk of cardiovascular mortality among lymphoma survivors relative to that of the general population. A systematic review and meta-analysis were conducted. Articles were identified in November 2016 by searching EMBASE, MEDLINE, and CINAHL databases. Observational studies were included if they assessed cardiovascular mortality in patients with lymphoma who survived for at least 5 years from time of diagnosis or if they had a median follow-up of 10 years. A pooled standardized mortality ratio (SMR) was estimated using a DerSimonian and Laird random-effects model. The Q and I<sup>2</sup> statistics were used to assess heterogeneity. Funnel plots and Begg's and Egger's tests were used to evaluate publication bias. Of the 7450 articles screened, 27 studies were included in the systematic review representing 46 829 Hodgkin and 14 764 non-Hodgkin lymphoma survivors. The pooled number of deaths attributable to cardiovascular disease among Hodgkin and non-Hodgkin disease was estimated to be 7.31 (95% CI: 5.29-10.10; I<sup>2</sup>  = 95.4%) and 5.35 (95% CI: 2.55-11.24; I<sup>2</sup>  = 94.0%) times that of the general population, respectively. This association was greater among Hodgkin lymphoma survivors treated before the age of 21 (pooled SMR = 13.43; 95% CI: 9.22-19.57; I<sup>2</sup>  = 78.9%). There was a high degree of heterogeneity and a high risk of bias due to confounding in this body of literature. Lymphoma survivors have an increased risk of fatal cardiovascular events compared to the general population and should be targeted for cardiovascular screening and prevention campaigns.</AbstractText>                <CopyrightInformation>© 2018 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Boyne</LastName>                    <ForeName>Devon J</ForeName>                    <Initials>DJ</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6301-2429</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mickle</LastName>                    <ForeName>Alexis T</ForeName>                    <Initials>AT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brenner</LastName>                    <ForeName>Darren R</ForeName>                    <Initials>DR</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Friedenreich</LastName>                    <ForeName>Christine M</ForeName>                    <Initials>CM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cheung</LastName>                    <ForeName>Winson Y</ForeName>                    <Initials>WY</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tang</LastName>                    <ForeName>Karen L</ForeName>                    <Initials>KL</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wilson</LastName>                    <ForeName>Todd A</ForeName>                    <Initials>TA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lorenzetti</LastName>                    <ForeName>Diane L</ForeName>                    <Initials>DL</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>James</LastName>                    <ForeName>Matthew T</ForeName>                    <Initials>MT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ronksley</LastName>                    <ForeName>Paul E</ForeName>                    <Initials>PE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rabi</LastName>                    <ForeName>Doreen M</ForeName>                    <Initials>DM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>University of Calgary Ruby Doctoral Recruitment Scholarship</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Faculty of Graduate Studies Doctoral Scholarship</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Queen Elizabeth II Graduate Scholarship</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Alberta Innovates Health Solutions Health Senior Scholar Award</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Alberta Cancer Foundation Weekend to End Women's Cancers Breast Cancer Chair</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Roy and Vi Baay Chair in Kidney Research Award</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>15</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cancer Med</MedlineTA>            <NlmUniqueID>101595310</NlmUniqueID>            <ISSNLinking>2045-7634</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2015 Apr 28;112(9):1575-84</RefSource>                <PMID Version="1">25867256</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1998 Nov;16(11):3592-600</RefSource>                <PMID Version="1">9817280</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Jan 20;34(3):235-43</RefSource>                <PMID Version="1">26573075</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2013 May;10(5):289-301</RefSource>                <PMID Version="1">23529000</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Blood Marrow Transplant. 2016 May;22(5):782-95</RefSource>                <PMID Version="1">26802323</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Sex Med. 2011 Jul;8(7):1833-41</RefSource>                <PMID Version="1">21324087</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2012 May 24;119(21):4845-50</RefSource>                <PMID Version="1">22496152</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2017 Jan;18(1):e11-e18</RefSource>                <PMID Version="1">28049573</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2015 Jul 16;126(3):346-53</RefSource>                <PMID Version="1">26048910</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Hematol. 2016 Jul;53(3):209-15</RefSource>                <PMID Version="1">27496313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hematol Oncol Clin North Am. 2008 Apr;22(2):233-44, vi</RefSource>                <PMID Version="1">18395147</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1155-7</RefSource>                <PMID Version="1">2254106</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2014 Feb 18;110(4):868-74</RefSource>                <PMID Version="1">24434433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Blood Cancer. 2012 Mar;58(3):421-7</RefSource>                <PMID Version="1">21910209</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2012 Mar 7;104(5):357-70</RefSource>                <PMID Version="1">22312134</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Cardiol. 2013 Jun 11;61(23):2319-28</RefSource>                <PMID Version="1">23583253</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Intern Med. 2008 Mar 10;168(5):469-76</RefSource>                <PMID Version="1">18332290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2014 Jun 10;32(17):1840-50</RefSource>                <PMID Version="1">24733803</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cardiol. 2013 Dec 15;112(12):1980-4</RefSource>                <PMID Version="1">24075281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 1999 Apr;51(1):35-42</RefSource>                <PMID Version="1">10386715</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Contemp Oncol (Pozn). 2015;19(2):93-7</RefSource>                <PMID Version="1">26034385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1996 Nov 1;36(4):881-9</RefSource>                <PMID Version="1">8960517</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Intern Med. 2015 Jun;175(6):1007-17</RefSource>                <PMID Version="1">25915855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Leuk Lymphoma. 2005 Jul;46(7):1023-8</RefSource>                <PMID Version="1">16019553</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Radiat Oncol. 1996 Jul;6(3):225-242</RefSource>                <PMID Version="1">10717180</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):867-77</RefSource>                <PMID Version="1">10386644</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2013 Apr 10;31(11):1435-41</RefSource>                <PMID Version="1">23439756</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):169-79</RefSource>                <PMID Version="1">10924987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Blood Cancer. 2013 Apr;60(4):543-9</RefSource>                <PMID Version="1">23281199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 1998 Jan;46(1):51-62</RefSource>                <PMID Version="1">9488128</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Endocrinol. 2016 Jun;12(6):319-36</RefSource>                <PMID Version="1">27032982</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Surviv. 2013 Sep;7(3):300-22</RefSource>                <PMID Version="1">23475398</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Adolesc Young Adult Oncol. 2016 Jun;5(2):159-73</RefSource>                <PMID Version="1">26885683</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Haematol. 2016 Mar;172(5):757-68</RefSource>                <PMID Version="1">26727959</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2016 Mar 02;352:i851</RefSource>                <PMID Version="1">26936410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2015 Mar;16(3):e123-36</RefSource>                <PMID Version="1">25752563</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 1993 Oct 27;270(16):1949-55</RefSource>                <PMID Version="1">8411552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2002 Apr 15;20(8):2101-8</RefSource>                <PMID Version="1">11956271</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Blood Cancer. 2017 Jul;64(7):null</RefSource>                <PMID Version="1">28205419</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2014 Jan;14(1):61-70</RefSource>                <PMID Version="1">24304873</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2010 Jun;46(9):1632-9</RefSource>                <PMID Version="1">20219350</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1999 Oct;17(10):3207-15</RefSource>                <PMID Version="1">10506620</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 2014 Mar;110(3):448-54</RefSource>                <PMID Version="1">24231235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2000 Apr 19;283(15):2008-12</RefSource>                <PMID Version="1">10789670</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hematology Am Soc Hematol Educ Program. 2011;2011:323-9</RefSource>                <PMID Version="1">22160053</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2015 Feb 23;107(4):null</RefSource>                <PMID Version="1">25713164</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Haematol. 2008 Jul;142(1):11-26</RefSource>                <PMID Version="1">18430191</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 1994 Jul 16;309(6948):162-6</RefSource>                <PMID Version="1">8044095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2010 Jun 03;17(3):R141-59</RefSource>                <PMID Version="1">20453080</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Psychol. 2015 Feb;34(2):130-48</RefSource>                <PMID Version="1">25133839</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2014 Oct;11(10):597-609</RefSource>                <PMID Version="1">25113839</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Apr 1;136(7):1655-64</RefSource>                <PMID Version="1">25110999</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2007 Feb 7;99(3):206-14</RefSource>                <PMID Version="1">17284715</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Oct 10;29(29):3900-6</RefSource>                <PMID Version="1">21911724</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Nov-Dec;65(6):428-55</RefSource>                <PMID Version="1">26348643</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neurosci Biobehav Rev. 2015 Jun;53:108-20</RefSource>                <PMID Version="1">25857254</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Hematol Malig Rep. 2008 Jul;3(3):119-25</RefSource>                <PMID Version="1">20425456</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Med Sci. 2016 Apr 1;12(2):428-35</RefSource>                <PMID Version="1">27186191</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Haematol. 2014 Mar;164(6):851-7</RefSource>                <PMID Version="1">24433418</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1998 Apr;77(8):1300-10</RefSource>                <PMID Version="1">9579837</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2008 Oct 1;100(19):1368-79</RefSource>                <PMID Version="1">18812549</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2015 Jan;32(1):422</RefSource>                <PMID Version="1">25471791</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J R Soc Med. 2015 Jan;108(1):32-7</RefSource>                <PMID Version="1">25572993</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 May 10;29(14):1885-92</RefSource>                <PMID Version="1">21483015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 May-Jun;65(3):167-89</RefSource>                <PMID Version="1">25683894</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2018 Sep;7(9):4801-4813</RefSource>                <PMID Version="1">30112841</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cardiol. 2011 Feb 1;107(3):472-7</RefSource>                <PMID Version="1">21257017</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circulation. 2016 Nov 15;134(20):1519-1531</RefSource>                <PMID Version="1">27821538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1993 Jul;11(7):1208-15</RefSource>                <PMID Version="1">8315419</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cardiol Young. 2015 Aug;25 Suppl 2:107-16</RefSource>                <PMID Version="1">26377717</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 2000 May;55(2):153-62</RefSource>                <PMID Version="1">10799727</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Med. 2015;66:161-76</RefSource>                <PMID Version="1">25587648</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2013 Jul;14(8):721-32</RefSource>                <PMID Version="1">23759376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Leuk Lymphoma. 2000 Oct;39(3-4):311-9</RefSource>                <PMID Version="1">11342311</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circulation. 2016 Mar 15;133(11):1104-14</RefSource>                <PMID Version="1">26976915</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2016 Jul;66(4):271-89</RefSource>                <PMID Version="1">27253694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Leuk Lymphoma. 2001 Aug;42(4):631-7</RefSource>                <PMID Version="1">11697491</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2003 Sep 15;21(18):3431-9</RefSource>                <PMID Version="1">12885835</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Children (Basel). 2015;2(1):1-36</RefSource>                <PMID Version="1">25692094</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Leuk Lymphoma. 2013 May;54(5):979-85</RefSource>                <PMID Version="1">23098058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Circulation. 2017 Mar 7;135(10):951-963</RefSource>                <PMID Version="1">28082386</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer J Sci Am. 1995 May-Jun;1(1):33-42</RefSource>                <PMID Version="1">9166452</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Hodgkin</Keyword>            <Keyword MajorTopicYN="N">cardiovascular disease</Keyword>            <Keyword MajorTopicYN="N">lymphoma</Keyword>            <Keyword MajorTopicYN="N">meta-analysis</Keyword>            <Keyword MajorTopicYN="N">mortality</Keyword>            <Keyword MajorTopicYN="N">standardized mortality ratio</Keyword>            <Keyword MajorTopicYN="N">survivors</Keyword>            <Keyword MajorTopicYN="N">systematic review</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>04</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30112841</ArticleId>            <ArticleId IdType="doi">10.1002/cam4.1572</ArticleId>            <ArticleId IdType="pmc">PMC6143935</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>